OpenVSafe by OpenVAERS
Search V-safe

ZTA-30966-81540

2 vaccinations 5 coded responses 7 check-ins 5 free-text entries 5 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
240 / VA
Registered
2021-06-27
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1440664 (opens in a new window) high 9 / 11 1 1 of 14 VAERS symptoms same dose (2) VA matches 2021-06-18 / 2021-06-20 / 2021-07-01
received 6 days before the last call
case 821979

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-05-28
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-18
    Dose 2 — Pfizer-BioNTech
  3. 2021-06-27
    Registered in v-safe
  4. 2021-06-27
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-06-27
    Report sent to call center — day 7, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-07-01
  7. 2021-07-01
    Call successful
    Completed over the phone
  8. 2021-07-02
    Survey response — day 14, dose 2
    MedDRA: Anaphylactic shock, Aphonia — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Anaphylactic shock 6/28/21 and 6/30/21. Issue talking, losing voice long periods of time.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-07-02
    Report sent to call center — day 14, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-07-07
    Call successful
    Reported to VAERS during previous contact from GDIT
  11. 2021-07-09
    Survey response — day 21, dose 2
    MedDRA: Anaphylactic shock — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Anaphylaxic shock
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-07-09
    Report sent to call center — day 21, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  13. 2021-07-14
  14. 2021-07-18
    Survey response — day 28, dose 2
    MedDRA: Dysphagia, Dysphonia, Lymphadenopathy, Office visit, Oropharyngeal pain, Peripheral swelling — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Sore throat, lymph node swelling in both armpits and right arm. Swelling in hands, feet, legs. Troublesome swallowing, voice reduction. · Healthcare visit (other): Dr. Visit in person 7/16
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-07-18
    Report sent to call center — day 28, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-07-25
  17. 2021-07-30
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  18. 2021-09-17
    Survey response — 3 months, dose 2
    MedDRA: Blood pressure increased, Office visit, Swelling, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Higher blood pressure. BP had been 140s before shot after shot 150+ but Wed. 9/15 allergist visit was 188/123. Allergist started blood pressure rx immediately. Unable to take Ibuprofen for swelling. Can't take Prednisone since had for 3 weeks. · Healthcare visit (other): Bloodwork-SARS COVID antibodies and liver and kidney function
    MedDRA releases: 2024-11 · check-in free text available
  19. 2021-09-17
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-09-21
  21. 2021-09-23
  22. 2021-09-24
  23. 2021-09-24
  24. 2021-09-28
    Call successful
    Participant prefers to complete VAERS report online
  25. 2021-12-17
    Health check-in — 6 months, dose 2
    Feeling: Poor
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-05-28Pfizer-BioNTech No
22021-06-18Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-06-27 Successful
2021-07-01
Completed over the phone
2021-07-02 Successful
2021-07-07
Reported to VAERS during previous contact from GDIT
2021-07-09 Unsuccessful Reported to VAERS voluntarily prior to GDIT contact
2021-07-18 Unsuccessful
2021-09-17 Successful
2021-09-28
Participant prefers to complete VAERS report online

Free text

Release 9 — day 7, dose 2

2021-06-27

Systemic reaction (other): Swollen lymph nodes

Release 9 — day 14, dose 2

2021-07-02

Symptoms: Anaphylactic shock 6/28/21 and 6/30/21. Issue talking, losing voice long periods of time.

Release 9 — day 21, dose 2

2021-07-09

Symptoms: Anaphylaxic shock

Release 9 — day 28, dose 2

2021-07-18

Symptoms: Sore throat, lymph node swelling in both armpits and right arm. Swelling in hands, feet, legs. Troublesome swallowing, voice reduction.
Healthcare visit (other): Dr. Visit in person 7/16

Release 9 — 3 months, dose 2

2021-09-17

Symptoms: Higher blood pressure. BP had been 140s before shot after shot 150+ but Wed. 9/15 allergist visit was 188/123. Allergist started blood pressure rx immediately. Unable to take Ibuprofen for swelling. Can't take Prednisone since had for 3 weeks.
Healthcare visit (other): Bloodwork-SARS COVID antibodies and liver and kidney function

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOUnevaluable event · · ✓
SDAnaphylactic shock ✓ ✓ ✓
SDAphonia ✓ ✓ ✓
SDBlood pressure increased · · ✓
SDDysphagia · · ✓
SDDysphonia · · ✓
SDLymphadenopathy · · ✓
SDOffice visit · · ✓
SDOropharyngeal pain · · ✓
SDPeripheral swelling · · ✓
SDSwelling · · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release